Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human

Drug Metabolism and Disposition

Volumn 24, Issue 10, 1996, Pages 1134-1138

  Mclellan, Roman A ^a   Drobitch, Robert K ^a   Monshouwer, Mario ^a   Renton, Kenneth W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLOFIBRATE; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; ERYTHROMYCIN; ETHOXYRESORUFIN DEETHYLASE; NORFLOXACIN; OLIVE OIL; PYRIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM CHLORIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; DEMETHYLATION; DRUG METABOLISM; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ISOENZYMES; MICROSOMES, LIVER; NORFLOXACIN; RATS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0029858260     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. M. Neuman: Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Clin. Pharmacokinet. 14, 96-121 (1988).
2. J. R. B. J. Brouwers: Pharmacokinetics of the newer fluoroquinolones. Pharm. Weekbl. Sci. 9, 16-22 (1987).
3. R. Wise, D. Lister, C. A. M. McNally, D. Grugg, and J. M. Andrews: The comparative pharmacokinetics of five quinolones. J. Antimicrobial Chemotherap. 18, (Suppl. D) 71-81 (1986).
4. F. Sörgel: Metabolism of gyrase inhibitors. Rev. Infect. Dis. 11, (Suppl. 5) S1119-S1129 (1989).
5. B. N. Swanson, V. K. Boppana, P. H. Vlasses, H. H. Rotmensch, and R. K. Ferguson: Norfloxacin disposition after sequentially increasing oral doses. Antimicrob. Agents Chemother. 23, 284-288 (1983).
6. W. J. A. Wijnands, T. B. Vree, and C. L. A. Van Herwaarden: The influence of quinolone derivatives on theophylline clearance. Br. J. Clin. Pharmacol. 22, 677-683 (1986).
7. J. G. Gillum, D. S. Israel, and R. E. Polk: Pharmacokinetic drug interactions with antimicrobial agents. Clin. Pharmacokinet. 25, 450-482 (1993).
8. J. Combalbert, I. Fabre, G. Fabre, et al.: Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin inducible human liver cytochrome P450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab. Dispos. 17, 197-207 (1989).
9. J. C. Kolars, P. L. Stetson, B. D. Rush, et al.: Cyclosporine A metabolism by P450IIIA in rat enterocytes: another determinant of oral bioavailability? Transplantation 53, 596-602 (1992).
10. G. C. Yee and T. R. McGuire: Pharmacokinetic drug interactions with cyclosporin (part I). Clin. Pharmacokinet. 19, 319-332 (1990).
11. G. C. Yee and T. R. McGuire: Pharmacokinetic drug interactions with cyclosporin (part II). Clin. Pharmacokinet. 19, 400-415 (1990).
12. J. M. Radandt, C. R. Marchbanks, and M. N. Dudley: Interactions of fluoroquinolones with other drugs: Mechanisms, variability, clinical significance, and management. Clin. Infect. Dis. 14, 272-284 (1992).
13. D. J. Thomson, A. H. Menkis, and F. N. McKenzie: Norfloxacin-cyclosporine A interaction. Transplantation 46, 312-313 (1988).
14. M. Jadoul, Y. Pirson, and C. van Ypersele de Strihou: Norfloxacin and cyclosporine A: a safe combination. Transplantation 47, 747-748 (1989).
15. J. A. Robinson, F. R. Venezio, M. R. Costanzo-Nordin, R. Pifarre, and P. J. O'Keefe: Patients receiving quinolones and cyclosporine A after heart transplantation. J. Heart Transplant 9, 30-31 (1990).
16. L. L. Hoey and K. D. Lake: Does ciprofloxacin interact with cyclosporine A? Ann. Pharmacother. 28, 93-96 (1994).
17. R. A. McLellan, R. K. Drobitch, D. H. McLellan, P. D. Acott, J. F. S. Crocker, and K. W. Renton: Norfloxacin interferes with cyclosporine A disposition in pediatric patients undergoing renal transplantation. Clin. Pharmacol. Ther. 58, 322-327 (1995).
18. S. El Defrawry El Masry, G. M. Cohen, and G. J. Mannering: Temporal changes in the microsomal drug metabolizing system of the liver during sexual maturation. Drug Metab. Dispos. 2, 267-278 (1974).
19. O. H. Lowry, N. J. Rosenbrough, A. L, Fair, and R. J. Randall: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
20. T. Omura and R. Sato: The carbon monoxide-binding pigment of liver microsomes: evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378 (1964).
21. M. A. Arlotto, A. J. Sonderfan, C. D. Klaassen, and A. Parkinson: Studies on the pregnenolone 16-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyl transferase. Biochem. Pharmacol. 36, 3859-3866 (1987).
22. M. D. Burke, R. A. Prough, and R. T. Mayer: Characteristics of a microsomal cytochrome P-448-mediated reaction ethoxyresorufin O-de-ethylation. Drug Metab. Dispos. 5, 1-8 (1977).
23. D. R. Koop: Hydroxylation of p-nitiophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 29, 399-404 (1986).
24. G. L. Parker and G. C. Orton: Induction of oxyisobutyrates of hepatic and kidney microsomal cytochrome P-450 with specificity towards hydroxylation of fatty acids. In "Biochemistry, Biophysics, and Regulation of Cytochrome P-450" (J.-Å. Gustafsson, J. Carlstedt-Duke, A. Mode, and J. Rafter, eds.), pp. 373-377. Elsevier/North-Holland Biomedical Press, New York, 1980.
25. B. J. Smith: SDS polyacrylamide gel electrophoresis of proteins. In "Methods in Molecular Biology. Volume 1. Proteins" (J. M. Walker, ed.), pp. 41-55. Humana Press, Clifton, NJ, 1984.
26. A. Parkinson and B. Gemzik: Production and purification of antibodies against rat liver P450 enzymes. In "Methods in Enzymology. Volume 206. Cytochrome P450" (M. R. Waterman and E. F. Johnson, eds.), pp. 233-245. Academic Press, San Diego, CA, 1991.
27. L. Pichard, I. Fabre, G. Fabre, et al.: Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab. Dispos. 18, 595-606 (1990).
28. S. Harder, U. Fuhr, H. Staib, and T. Wolff: Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations. Am. J. Med. 87, (Suppl. 5A) 89S-91S (1989).
29. T. A. Tassaneeyakul, D. J. Birkett, M. E. McManus, W. Tassaneeyakul, M. E. Veronese, T. Andersson, R. H. Tukey, and J. O. Miners, Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Biochem. Pharmacol. 47, 1767-1776 (1994).
30. H. R. Ha, J. A. Chen, A. U. Freiburghaus, and F. Follath, Metabolism of theophylline by cDNA expressed human cytochromes P-450. Br. J. Clin. Pharmacol. 39, 321-326, (1995).
31. R. A. Robson, E. J. Begg, H. C. Atkinson, D. A. Saunders, and C. M. Frampton: Competitive effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline. Br. J. Clin. Pharmacol. 29, 491-493 (1990).
32. M. Sarkar, R. E. Polk, P. S. Guzelian, C. Hunt, and H. T. Karnes: In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes. Antimicrob. Agents Chemother. 34, 594-599 (1990).
33. O. Okazaki, T. Kurata, and H. Tachizawa: Effect of new quinolones on drug-metabolizing enzyme system of rat hepatic microsomes. Chemotherapy 34, 149-154 (1988).
34. H.U. Kruger, U. Schuer, B. Proksch, M. Gobel, and G. Ehninger: Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipients. Antimicrob. Agents Chemother. 34, 1048-1052 (1990).
35. D.H. va Buren, J. Koestner, A. Adenoyin, T. McCune, R. MacDonell, H. K. Johnson, J. Carroll, W. Nylander, and R. E. Richie:. Effect of ciprofloxacin on cyclosporine pharmacokinetics. Transplantation 50, 888-889, 1990.
36. G. Barnett, J. Segura, R. De la Torre, and M. Carbo: Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition. Eur. J. Clin. Pharmacol. 39, 63-69 (1990).
37. R. Janknegt: Drug interactions with quinolones J. Antimicrob. Chemother. 26, (Suppl. D) 7-29 (1990).
38. T. H. Grasela and M. W. Dreis: An evaluation of quinolone theophylline interaction using the food and drug administration spontaneous reporting system. Arch. Intern. Med. 152, 617-621 (1992).